CAFC affirms validity of AbCellera's microfluidic cell culture patent against Bruker challenge

AbCellera Biologics Inc.

Federal Circuit affirms PTAB decision upholding all claims of U.S. Patent No. 10,087,408.
Patent covers microfluidic devices for culturing and selective recovery of cells.
Bruker Cellular (formerly Berkeley Lights) challenged validity on anticipation/obviousness grounds; both PTAB and CAFC rejected arguments.
Ongoing multi-patent infringement suit between AbCellera and Bruker pending in N.D. California.
AbCellera CEO expects to prove infringement case against Bruker in district court.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.